Impact of Evolocumab on the Antiplatelet Effects of Ticagrelor and Aspirin in Patients With Acute Coronary Syndrome
Latest Information Update: 04 Apr 2024
At a glance
- Drugs Aspirin (Primary) ; Evolocumab (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms EvoACS
- 21 Jun 2022 New trial record